Navigate BioPharma Achieves ISO 15189:2012 Accreditation Success
Navigating Excellence: ISO Accreditation Secured by Navigate BioPharma
At the heart of laboratory services, quality and safety play critical roles in patient care. Navigate BioPharma Services, Inc. has reached a notable milestone by obtaining accreditation to the ISO 15189:2012 standard, awarded by the esteemed College of American Pathologists (CAP).
Understanding ISO 15189:2012 Accreditation
The ISO 15189 standard serves as a benchmark for technical competence and management in medical laboratories. It ensures that labs meet stringent quality standards and are committed to continual improvement, all while enhancing patient safety and decreasing risks associated with laboratory practices.
The Importance of CAP and Its Accreditation Programs
CAP, recognized by the Centers for Medicare and Medicaid Services, plays a vital role in laboratory accreditation. The CAP 15189 program is a voluntary initiative that supplements existing CLIA-based lab accreditation systems. It emphasizes the necessity for high-quality standards while also minimizing the possibility of errors, ultimately benefiting healthcare providers and their patients.
Enhancing Patient Care with Robust Standards
This recent accreditation aligns with Navigate BioPharma's mission to elevate healthcare quality. The CAP 15189 program not only reinforces current processes but also assists laboratories in establishing frameworks for continuous quality enhancement.
Expert Insights on the Accreditation's Impact
Leaders within Navigate BioPharma spoke about the importance of this achievement. Dr. Vipul Trivedi, MD FCAP, Chair of the CAP 15189 Committee, remarked, "The ISO 15189 standard provides laboratories with a structured framework to foster continuous improvement. It ensures that we are focused on delivering top-quality laboratory care to patients through methods like risk assessment and process enhancements."
Echoing this sentiment, Shannon Sykes, Head of Quality at Navigate BioPharma, shared, "This accreditation underlines our unwavering commitment to quality and patient care. It reflects our ongoing journey toward excellence within laboratory services, demonstrating our dedication to continuous operational improvements."
About Navigate BioPharma
Navigate BioPharma Services, Inc. operates as a standout entity within the Novartis group, specializing in groundbreaking biomarker and bioanalytical solutions tailored for clinical development and companion diagnostics. Over the last ten years, the company has developed a comprehensive library of assays and methodologies, achieving significant success in creating validated assays for diverse therapeutic and diagnostic applications.
Navigate’s Commitment to Its Clients
Navigate BioPharma takes pride in its reputation for delivering high-quality, reliable, and precise solutions. By leveraging their extensive experience, they empower their customers and partners to make informed decisions regarding drug development and patient care.
Get In Touch
If you are interested in how Navigate BioPharma can support your organization in various clinical trial studies, feel free to reach out to Nick Sanna, Head of Business Development & Strategic Alliances at Navigate BioPharma. You can contact him at (760) 602-1409.
Frequently Asked Questions
What does ISO 15189:2012 accreditation entail?
ISO 15189:2012 accreditation focuses on ensuring the quality and competence of medical laboratories. It establishes specific requirements for quality management systems and technical competence.
Who awarded the accreditation to Navigate BioPharma?
The College of American Pathologists (CAP) awarded the accreditation, recognizing Navigate BioPharma's commitment to excellence in laboratory services.
How does this accreditation impact patient care?
This accreditation enhances patient care by improving laboratory processes, increasing safety measures, and minimizing the risk of errors in testing and diagnosis.
What is Navigate BioPharma's role in clinical development?
Navigate BioPharma provides innovative biomarker and bioanalytical solutions aimed at advancing clinical development and companion diagnostics.
How can I learn more about Navigate BioPharma's services?
For more information regarding their services and solutions, you can visit their website or contact their business development team directly.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
